» Articles » PMID: 16109430

Cannabinoid Signalling

Overview
Journal Life Sci
Publisher Elsevier
Date 2005 Aug 20
PMID 16109430
Citations 175
Authors
Affiliations
Soon will be listed here.
Abstract

After their discovery, the two known cannabinoid receptors, CB(1) and CB(2), have been the focus of research into the cellular signalling mechanisms of cannabinoids. The initial assessment, mainly derived from expression studies, was that cannabinoids, via G(i/o) proteins, negatively modulate cyclic AMP levels, and activate inward rectifying K(+) channels. Recent findings have complicated this assessment on different levels: (1) cannabinoids include a wide range of compounds with varying profiles of affinity and efficacy at the known CB receptors, and these profiles do not necessarily match their biological activity; (2) CB receptors appear to be intrinsically active and possibly coupled to more than one type of G protein; (3) CB receptor signalling mechanisms are diverse and dependent on the system studied; (4) cannabinoids have other targets than CB receptors. The aim of this mini review is to discuss the current literature regarding CB receptor signalling pathways. These include regulation of adenylyl cyclase, MAP kinase, intracellular Ca(2+), and ion channels. In addition, actions of cannabinoids that are not mediated by CB(1) or CB(2) receptors are discussed.

Citing Articles

CamKIIα and VPAC1 Expressions in the Caudal Trigeminal Nucleus of Rats After Systemic Nitroglycerin Treatment: Interaction with Anandamide.

Nagy-Grocz G, Spekker E, Kortesi T, Laborc K, Bohar Z, Fejes-Szabo A Life (Basel). 2025; 15(2).

PMID: 40003563 PMC: 11856001. DOI: 10.3390/life15020155.


Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders.

Kumar U Int J Mol Sci. 2025; 26(1.

PMID: 39796008 PMC: 11720483. DOI: 10.3390/ijms26010152.


The Anticancer Activity of Cannabinol (CBN) and Cannabigerol (CBG) on Acute Myeloid Leukemia Cells.

Kadriya A, Forbes-Robertson S, Falah M Molecules. 2025; 29(24.

PMID: 39770061 PMC: 11676644. DOI: 10.3390/molecules29245970.


RNAi Screen Identifies AXL Inhibition Combined with Cannabinoid WIN55212-2 as a Potential Strategy for Cancer Treatment.

Li F, Gong H, Jia X, Gao C, Jia P, Zhao X Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598377 PMC: 11597789. DOI: 10.3390/ph17111465.


Exploring Endocannabinoid System: Unveiling New Roles in Modulating ER Stress.

Capolupo I, Miranda M, Musella S, Di Sarno V, Manfra M, Ostacolo C Antioxidants (Basel). 2024; 13(11).

PMID: 39594426 PMC: 11591047. DOI: 10.3390/antiox13111284.